Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

A High Degree of Engrafting Unit-Recipient HLA-Allele Mismatch Is Not Associated with an Increased Risk of Transplant-Related Mortality (TRM) or Inferior Progression-Free Survival (PFS) after Double Unit Cord Blood (CB) Transplantation (dCBT) in Adults with Hematologic Malignancies

Blood (2018) 132 (Supplement 1): 3470.

https://doi.org/10.1182/blood-2018-99-116477

Published: 2018

Journal Articles

Evaluation of Cord Blood (CB) Unit TNC & CD34+ Cell Content & Donor-Recipient High-Resolution 8 HLA-Allele Match By Patient Ancestry: An Evaluation of 513 CB Units in a Racially & Ethnically Diverse Population of Adults with Hematologic Malignancies

Christopher Mazis, BS, Ioannis Politikos, MD, Sean M Devlin, PhD, Molly Maloy, MS, Eric Davis, MPH, Candice Cooper, Melissa Nhaissi, MPH, Beth Suri, Deborah Wells, Sergio Giralt, MD, Gunjan L. Shah, MD, Marcel R.M. van den Brink, MD PhD, Nancy A. Kernan, Andromachi Scaradavou, MD, Juliet Barker, MBBS

Blood (2018) 132 (Supplement 1): 3342.

https://doi.org/10.1182/blood-2018-99-116598

Published: 2018

Journal Articles

Impact of CD34 Cell Dose Infused on the Duration of Absolute Neutropenia after High Dose Melphalan and Autologous HCT for Myeloma

Lizamarie Bachier Rodriguez, MD, Gunjan L. Shah, MD, Andrea Knezevic, MS, Sean M Devlin, PhD, Molly Maloy, MS, Guenther Koehne, MD PhD, David J. Chung, MD PhD, Heather J. Landau, MD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 2156.

https://doi.org/10.1182/blood-2018-99-119537

Published: 2018

Journal Articles

The Prognostic Calculator Easix Predicts Acute Gvhd, Non-Relapse Mortality and Overall Survival in Adult Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

Miriam Sanchez-Escamilla, Patrick Hilden, MS, Molly Maloy, MS, Samira A Fatmi, BS, Doris Ponce, MD, Craig S. Sauter, MD, Sergio Giralt, MD, Miguel-Angel Perales, MD

Blood (2018) 132 (Supplement 1): 2069.

https://doi.org/10.1182/blood-2018-99-111036

Published: 2018

Journal Articles

A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Richard J Lin, MD PhD, Theresa A Elko, MS, Sean M Devlin, PhD, Ann A. Jakubowski, MD PhD, Armin Shahrokni, MD, Parastoo B. Dahi, MD, Miguel-Angel Perales, MD, Roni Tamari, MD, Brian C. Shaffer, MD, Craig S. Sauter, MD, Esperanza B. Papadopoulos, MD, H.R. Castro-Malaspina, MD, Juliet Barker, MBBS, Molly Maloy, MS, Beatriz Korc-Grodzicki, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 2176.

https://doi.org/10.1182/blood-2018-99-113688

Published: 2018

Journal Articles

Dysgeusia Is Associated with Higher Melphalan Pharmacokinetic Levels and Results in Poorer Caloric Intake and Worse Symptom Burden after Autologous Stem Cell Transplantation for Multiple Myeloma

Michael Scordo, MD, Gunjan L. Shah, MD, Elaina V. Preston, PA-C, MPH, Natasia Rodriguez, BSN, RN, Andrew Lin, PharmD, BCOP, Molly Maloy, MS, Brooke Mastrogiacomo, BS, Dean Carlow, MD PhD, Ryan Schofield, MS, Andrea Knezevic, MS, Sean M Devlin, PhD, Heather J. Landau, MD, David J. Chung, MD PhD, Jonathan U. Peled, MD PhD, Marissa L. Buchan, MS, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 2136.

https://doi.org/10.1182/blood-2018-99-114715

Published: 2018

Journal Articles

Loss of Microbiota Diversity after Autologous Stem Cell Transplant Is Comparable to Injury in Allogeneic Stem Cell Transplant

Blood (2018) 132 (Supplement 1): 608.

https://doi.org/10.1182/blood-2018-99-110857

Published: 2018

Journal Articles

HLA-a*0101 Expression Correlates with Increased Risk of Severe Cutaneous Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Maira Fonseca, MD, Ann A. Jakubowski, MD PhD, Sean M Devlin, PhD, James W. Young, MD, Samira A Fatmi, BS, Molly Maloy, MS, Sergio Giralt, MD, Doris Ponce, MD, Alina Markova, MD

Blood (2018) 132 (Supplement 1): 4564.

https://doi.org/10.1182/blood-2018-99-110405

Published: 2018

Journal Articles

CD34+Selected Hematopoietic Stem Cell Transplants Conditioned with a Myeloablative Regimen Is Well Tolerated and Results in Good Outcomes in Patients with Myelofibrosis

Jeong-Ok Lee, MD, Jessica Flynn, BS, Molly Maloy, MS, Ann A. Jakubowski, MD PhD, Esperanza B. Papadopoulos, MD, Christina Cho, MD, Doris Ponce, MD, Craig S. Sauter, MD, Miguel-Angel Perales, MD, Sean M Devlin, PhD, Sergio Giralt, MD, Hugo R. Castro-Malaspina, MD, Roni Tamari, MD

Blood (2018) 132 (Supplement 1): 4636.

https://doi.org/10.1182/blood-2018-99-113166

Published: 2018

Journal Articles

Effect of Obesity on the Efficacy and Toxicities in Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT) for Lymphoma

Nicole Pearl, PharmD, Andrew Lin, PharmD, BCOP, Patrick Hilden, MS, Larry W Buie, PharmD, BCOP, FASHP, Kevin Robinson, Molly Maloy, MS, Gunjan L. Shah, MD

Blood (2018) 132 (Supplement 1): 4617.

https://doi.org/10.1182/blood-2018-99-119554

Published: 2018

Journal Articles

Late Effects of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) in Elderly Patients with Lymphoma

Parastoo B. Dahi, MD, Chikaodi Obioha, Sheila Kenny, NP, Patrick Hilden, MS, Molly Maloy, MS, Alexander Geyer, MD, Wendy Schaffer, MD, Roni Tamari, MD, Craig S. Sauter, MD, Ann A. Jakubowski, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 4620.

https://doi.org/10.1182/blood-2018-99-112632

Published: 2018

Journal Articles

Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on Close Haplo-Winning CB Unit HLA-Match

Blood (2018) 132 (Supplement 1): 2078.

https://doi.org/10.1182/blood-2018-99-116276

Published: 2018

Journal Articles

Multicenter Microbiota Analysis Indicates That Pre-HCT Microbiota Injury Is Prevalent across Geography and Predicts Poor Overall Survival

Blood (2018) 132 (Supplement 1): 811.

https://doi.org/10.1182/blood-2018-99-116967

Published: 2018

Journal Articles

Pre-Transplant and Peri-d100 Gastrointestinal Dysbiosis Is Associated with the Subsequent Development of Chronic Graft-Versus-Host Disease

Kate A Markey, PhDMBBS, Antonio LC Gomes, PhD, Eric R. Littmann, BA, Sean M Devlin, PhD, Ann E. Slingerland, BSc, John B. Slingerland, BSc, Annelie Clurman, BA, Gillian Moore, BA, Samira A Fatmi, BS, Molly Maloy, MS, Eric G. Pamer, MD, Ying Taur, MD MPH, Sergio Giralt, MD, Miguel-Angel Perales, MD, Doris Ponce, MD, Jonathan U. Peled, MD PhD, Marcel R.M. van den Brink, MD PhD

Blood (2018) 132 (Supplement 1): 359.

https://doi.org/10.1182/blood-2018-99-110309

Published: 2018

Journal Articles

Burden and Impact of Geriatric Syndromes Associated with Allogeneic Hematopoietic Cell Transplantation in Older Adults

Richard J Lin, MD PhD, Theresa A Elko, MS, Patrick Hilden, MS, Parastoo B. Dahi, MD, Ann A. Jakubowski, MD PhD, Miguel-Angel Perales, MD, Juliet Barker, MBBS, H.R. Castro-Malaspina, MD, Brian C. Shaffer, MD, Armin Shahrokni, MD, Roni Tamari, MD, Esperanza B. Papadopoulos, MD, Craig S. Sauter, MD, Molly Maloy, MS, Beatriz Korc-Grodzicki, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 3370.

https://doi.org/10.1182/blood-2018-99-113876

Published: 2018

Journal Articles

Impact of Omitting Post-Transplant Mini-Methotrexate Doses in Allogeneic Hematopoietic Cell Transplantation: A Single-Center Retrospective Study

Andrew Lin, PharmD, Patrick Hilden, MS, Molly Maloy, MS, Ann A. Jakubowski, MD PhD, Esperanza B. Papadopoulos, MD, Craig S. Sauter, MD, Roni Tamari, MD, Doris Ponce, MD, Sergio A. Giralt, MD, Boglarka Gyurkocza, MD

Blood (2017) 130 (Supplement 1): 3255.

https://doi.org/10.1182/blood.V130.Suppl_1.3255.3255

Published: 2017

Journal Articles

CMV Reactivation Post CD34+ Selected Allo-HCT Has Adverse Outcomes on Blood Counts Recovery

Roni Tamari, MD, Christina Cho, MD, Patrick Hilden, MS, Taylor Borrill, BA, CCRP, Molly Maloy, MS, H.R. Castro-Malaspina, MD, Esperanza B. Papadopoulos, MD, Ann A. Jakubowski, MD PhD, Genovefa Papanicolaou, Sergio A. Giralt, MD, Miguel-Angel Perales, MD

Blood (2017) 130 (Supplement 1): 3319.

https://doi.org/10.1182/blood.V130.Suppl_1.3319.3319

Published: 2017

Journal Articles

Efficacy of Donor Lymphocyte Infusion in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplant for Myeloid and Lymphoid Malignancies: A Single Center Experience

Adam Bryant, MD, Sean M. Devlin, PhD, H.R. Castro-Malaspina, MD, Ann A. Jakubowski, MD PhD, Molly Maloy, MS, Esperanza B. Papadopoulos, MD, Sergio A. Giralt, MD, Miguel-Angel Perales, MD

Blood (2017) 130 (Supplement 1): 3277.

https://doi.org/10.1182/blood.V130.Suppl_1.3277.3277

Published: 2017

Journal Articles

Characterizing Ionizing Radiation Exposure after T-Cell Depleted Allogeneic Hematopoietic Cell Transplantation

Christina Cho, MD, Molly Maloy, MS, Sean M. Devlin, PhD, Omer Aras, MD, H.R. Castro-Malaspina, MD, Lawrence T. Dauer, PhD, Ann A. Jakubowski, MD PhD, Richard J. O'Reilly, MD, Esperanza B. Papadopoulos, MD, Miguel-Angel Perales, MD, Theodore S. Rappaport, PhD, Roni Tamari, MD, Marcel R.M. van den Brink, MD PhD, Sergio A. Giralt, MD

Blood (2017) 130 (Supplement 1): 5504.

https://doi.org/10.1182/blood.V130.Suppl_1.5504.5504

Published: 2017

Journal Articles

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

Jeremy Pappacena, PharmD, Valkal Bhatt, PharmD, BCOP, BCPS, Gunjan L. Shah, MD, Patrick Hilden, MS, Molly Maloy, MS, Larry W Buie, PharmD, BCOP, FASHP, Sergio A. Giralt, MD, Michael Scordo, MD

Blood (2017) 130 (Supplement 1): 1950.

https://doi.org/10.1182/blood.V130.Suppl_1.1950.1950

Published: 2017

NARROW

A High Degree of Engrafting Unit-Recipient HLA-Allele Mismatch Is Not Associated with an Increased Risk of Transplant-Related Mortality (TRM) or Inferior Progression-Free Survival (PFS) after Double Unit Cord Blood (CB) Transplantation (dCBT) in Adults with Hematologic Malignancies

Evaluation of Cord Blood (CB) Unit TNC & CD34+ Cell Content & Donor-Recipient High-Resolution 8 HLA-Allele Match By Patient Ancestry: An Evaluation of 513 CB Units in a Racially & Ethnically Diverse Population of Adults with Hematologic Malignancies

Impact of CD34 Cell Dose Infused on the Duration of Absolute Neutropenia after High Dose Melphalan and Autologous HCT for Myeloma

The Prognostic Calculator Easix Predicts Acute Gvhd, Non-Relapse Mortality and Overall Survival in Adult Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Dysgeusia Is Associated with Higher Melphalan Pharmacokinetic Levels and Results in Poorer Caloric Intake and Worse Symptom Burden after Autologous Stem Cell Transplantation for Multiple Myeloma

Loss of Microbiota Diversity after Autologous Stem Cell Transplant Is Comparable to Injury in Allogeneic Stem Cell Transplant

HLA-a*0101 Expression Correlates with Increased Risk of Severe Cutaneous Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

CD34+Selected Hematopoietic Stem Cell Transplants Conditioned with a Myeloablative Regimen Is Well Tolerated and Results in Good Outcomes in Patients with Myelofibrosis

Effect of Obesity on the Efficacy and Toxicities in Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT) for Lymphoma

Late Effects of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) in Elderly Patients with Lymphoma

Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on Close Haplo-Winning CB Unit HLA-Match

Multicenter Microbiota Analysis Indicates That Pre-HCT Microbiota Injury Is Prevalent across Geography and Predicts Poor Overall Survival

Pre-Transplant and Peri-d100 Gastrointestinal Dysbiosis Is Associated with the Subsequent Development of Chronic Graft-Versus-Host Disease

Burden and Impact of Geriatric Syndromes Associated with Allogeneic Hematopoietic Cell Transplantation in Older Adults

Impact of Omitting Post-Transplant Mini-Methotrexate Doses in Allogeneic Hematopoietic Cell Transplantation: A Single-Center Retrospective Study

CMV Reactivation Post CD34+ Selected Allo-HCT Has Adverse Outcomes on Blood Counts Recovery

Efficacy of Donor Lymphocyte Infusion in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplant for Myeloid and Lymphoid Malignancies: A Single Center Experience

Characterizing Ionizing Radiation Exposure after T-Cell Depleted Allogeneic Hematopoietic Cell Transplantation

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only